Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

Exercise isn't just good for preventing cancer—it can literally help kill cancer cells Intense physical activity dramatically increases blood flow and shear stress in your blood vessels, a mechanical force powerful enough to destroy circulating tumor cells By disrupting their ability to spread and form deadly metastases, exercise directly... show more

FoundMyFitness Clips

62,217 subscribers

32,275 Aufrufe • vor 1 Jahr •via X (Twitter)

Gesundheit & Wellness Bildung

Anya Rossi• Live Now

Private livecam show

7 Kommentare

Profilbild von FoundMyFitness Clips

FoundMyFitness Clipsvor 1 Jahr

Watch the full interview here:

Profilbild von FoundMyFitness Clips

FoundMyFitness Clipsvor 1 Jahr

Get "The Omega-3 Supplementation Guide" Our in-depth blueprint detailing tactics on how to choose the best omega-3 supplement, benefits, and more Totally free Sign up here:

Profilbild von Coach Tim Hall

Coach Tim Hallvor 1 Jahr

@doctorinigo may find this interesting

Profilbild von Limoverse

Limoversevor 1 Jahr

Incredible insight! It’s amazing how exercise goes beyond just health maintenance, actively supporting the body in fighting off cancer cells and reducing recurrence risks. The power of movement for prevention and survival is truly remarkable! 💪🏻

Profilbild von Ysn

Ysnvor 1 Jahr

Then, what may explain athletes with cancer?

Profilbild von Jan

Janvor 1 Jahr

Great interview. Powerful message regarding cancer and exercise.

Profilbild von Cobra

Cobravor 1 Jahr

Move more

Ähnliche Videos

The force of blood flow generated during vigorous-intensity exercise kills circulating tumor cells Vigorous exercise creates high shear stress inside blood vessels (a mechanical force that damaged cancer cells are uniquely vulnerable to, pushing them toward cell death) These are the same cells responsible for cancer recurrence and metastasis years after initial treatment By reducing their survival, vigorous exercise may meaningfully lower cancer mortality

The force of blood flow generated during vigorous-intensity exercise kills circulating tumor cells Vigorous exercise creates high shear stress inside blood vessels (a mechanical force that damaged cancer cells are uniquely vulnerable to, pushing them toward cell death) These are the same cells responsible for cancer recurrence and metastasis years after initial treatment By reducing their survival, vigorous exercise may meaningfully lower cancer mortality

FoundMyFitness Clips

31,042 Aufrufe • vor 8 Monaten

The shear force of blood flow generated during vigorous-intensity exercise kills circulating tumor cells When you work out, the increased blood flow creates higher shear stress in your blood vessels, making it harder for circulating tumor cells to survive These are the very cells responsible for spreading cancer to vital organs By reducing their chances of survival, exercise may play a crucial role in preventing deadly metastasis

The shear force of blood flow generated during vigorous-intensity exercise kills circulating tumor cells When you work out, the increased blood flow creates higher shear stress in your blood vessels, making it harder for circulating tumor cells to survive These are the very cells responsible for spreading cancer to vital organs By reducing their chances of survival, exercise may play a crucial role in preventing deadly metastasis

FoundMyFitness Clips

393,345 Aufrufe • vor 1 Jahr

High-intensity exercise can help fight cancer It doesn’t just burn calories—it "stirs the biological soup," triggering powerful changes in the body that reduce cancer risk By flooding the bloodstream with immune cells, lowering cancer-fueling hormones like insulin and IGF, and ramping up anti-inflammatory markers, intense workouts create a hostile environment for cancer to develop The harder you push, the stronger the protective effect

High-intensity exercise can help fight cancer It doesn’t just burn calories—it "stirs the biological soup," triggering powerful changes in the body that reduce cancer risk By flooding the bloodstream with immune cells, lowering cancer-fueling hormones like insulin and IGF, and ramping up anti-inflammatory markers, intense workouts create a hostile environment for cancer to develop The harder you push, the stronger the protective effect

FoundMyFitness Clips

124,525 Aufrufe • vor 1 Jahr

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,180 Aufrufe • vor 1 Monat

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 Aufrufe • vor 1 Monat

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 Aufrufe • vor 2 Jahren

You can be sedentary even if you're active and meeting meeting exercise guidelines. The solution? "Exercise snacks" or taking opportunities to turn ordinary everyday situations like 'taking the stairs' and making them a form of vigorous, unstructured exercise. Even three to four minutes of daily vigorous physical activity were linked with a 25-30% drop in overall mortality risk in a study involving 25,000 people. Increasing this activity to around nine minutes daily further reduced cardiovascular mortality by nearly 50% and cancer mortality by 40%. Listen to Dr. Martin Gibala (Martin Gibala) explain the benefits of short bursts of highly vigorous physical activity.

You can be sedentary even if you're active and meeting meeting exercise guidelines. The solution? "Exercise snacks" or taking opportunities to turn ordinary everyday situations like 'taking the stairs' and making them a form of vigorous, unstructured exercise. Even three to four minutes of daily vigorous physical activity were linked with a 25-30% drop in overall mortality risk in a study involving 25,000 people. Increasing this activity to around nine minutes daily further reduced cardiovascular mortality by nearly 50% and cancer mortality by 40%. Listen to Dr. Martin Gibala (Martin Gibala) explain the benefits of short bursts of highly vigorous physical activity.

Dr. Rhonda Patrick

202,474 Aufrufe • vor 2 Jahren

The Hidden Dangers of Peptides “It can’t detect whether it’s causing vascularization on a cancer cell. Cancer cells are so hungry when they form a tumor site, they say okay great, now we need blood vessels to survive, so they form their own blood vessel supply. And because they become so greedy, these tumor cells go out and metastasize all over your body, and you have no control over that. Whether it goes to your brain, spinal cord, you don’t know until stage four, and then you’re done.” Louisa Nicola

The Hidden Dangers of Peptides “It can’t detect whether it’s causing vascularization on a cancer cell. Cancer cells are so hungry when they form a tumor site, they say okay great, now we need blood vessels to survive, so they form their own blood vessel supply. And because they become so greedy, these tumor cells go out and metastasize all over your body, and you have no control over that. Whether it goes to your brain, spinal cord, you don’t know until stage four, and then you’re done.” Louisa Nicola

Shawn Ryan

603,301 Aufrufe • vor 3 Monaten

Cancer researcher William Makis believes that Florida’s investment into oncology research will prove Ivermectin’s efficacy as a supplement to chemotherapy. “I believe that we’ll be able to show what I’ve been seeing for the past year and a half: that most cancers respond to Ivermectin…chemo will kill most of the cancer cells and leave the cancer stem cells behind. If you add Ivermectin, now you can actually kill those cancer stem cells as well to prevent recurrence or metastasis in the future.”

Cancer researcher William Makis believes that Florida’s investment into oncology research will prove Ivermectin’s efficacy as a supplement to chemotherapy. “I believe that we’ll be able to show what I’ve been seeing for the past year and a half: that most cancers respond to Ivermectin…chemo will kill most of the cancer cells and leave the cancer stem cells behind. If you add Ivermectin, now you can actually kill those cancer stem cells as well to prevent recurrence or metastasis in the future.”

One America News

233,501 Aufrufe • vor 10 Monaten

2. Regular exercise. Seyfried emphasizes regular exercise as VITAL for preventing cancer by: • Improving mitochondrial function • Lowering blood sugar and inflammation • Supporting autophagy to clear damaged cells Here are some forms of exercise anyone can do: • Walking • Swimming • Strength training Any form of movement is better than none. Simply moving your body daily is the goal.

2. Regular exercise. Seyfried emphasizes regular exercise as VITAL for preventing cancer by: • Improving mitochondrial function • Lowering blood sugar and inflammation • Supporting autophagy to clear damaged cells Here are some forms of exercise anyone can do: • Walking • Swimming • Strength training Any form of movement is better than none. Simply moving your body daily is the goal.

Michael Morelli

1,249,722 Aufrufe • vor 1 Jahr

Research suggests that up to 40% of cancer cases could be prevented through lifestyle changes. The evidence is now overwhelming: exercise is not just supportive—it’s a therapeutic intervention that recalibrates tumor biology, enhances treatment tolerance, and improves survival outcomes. Today’s interview features Dr. Kerry Courneya. With over 600 peer-reviewed studies, he is one of the most influential figures in exercise oncology. Even if you aren't someone who has personally experienced cancer in one form or another, you need to watch this episode. Episode 99 is Available now on X, YouTube, Spotify, and Apple Podcasts. Chapters: 0:00 - Introduction 1:47 - Why exercise should be effortful 2:33 - How to meaningfully reduce risk of cancer 6:22 - What type of exercise is best? 7:59 - How exercise reduces risk—even for smokers and the obese 10:48 - Weekend-only exercise 13:49 - 150 vs. 300 minutes per week (more is better—up to a point) 16:03 - Why pre-diagnosis exercise matters 19:09 - Why resilience to cancer treatment starts with exercise 21:01 - Why low muscle mass drives cancer death 23:58 - Why BMI fails to measure true obesity 27:51 - Why daily activity isn't enough (structured exercise matters) 29:34 - Breaking up sedentary time—do ‘exercise snacks’ help? 31:50 - Supplements vs. exercise 32:32 - Where exercise fits with chemo and immunotherapy 35:30 - Why rest is not the best medicine 41:20 - Aerobic vs. resistance 42:13 - How weight training improves 'chemo completion' 44:41 - Why exercise creates vulnerability in cancer cells (limitations do apply) 47:09 - Why exercise might be crucial for tumor elimination 53:03 - Why cardio may be better at clearing tumor cells 56:18 - When cancer spreads quickly—and when it doesn't 57:43 - Why liquid biopsies may prevent over-treatment 1:02:56 - Exercise-sensitive vs. exercise-resistant cancers 1:06:06 - Prostate cancer therapy—why strength training matters 1:08:10 - When exercise is the only therapy—does it work? 1:09:26 - Why HIIT reduces PSA in prostate cancer 1:11:40 - Avoiding overtreatment—can exercise buy you time? 1:12:00 - Why high-intensity exercise boosts anti-cancer biology 1:13:11 - Turning a diagnosis into a wake-up call 1:16:11 - Why oncologists are rethinking exercise 1:18:50 - Why exercise eases anxiety about cancer—proven psychological benefits 1:25:00 - Before, during, and after treatment 1:27:02 - Why exercise is unique among cancer therapies 1:28:16 - Why cancer patients stop exercising—the risky mistake almost everyone makes 1:30:41 - How to get sedentary cancer patients exercising (realistically) 1:33:15 - The $1 million case for including exercise 1:34:56 - Why recurrence trials haven't convinced doctors—yet 1:37:36 - The bottom-line message 1:37:55 - The myth of a cancer panacea (exercise included) 1:44:07 - What's the best $50 investment for staying active? 1:44:40 - Only 15 minutes per day—what’s the best anti-cancer exercise?

Research suggests that up to 40% of cancer cases could be prevented through lifestyle changes. The evidence is now overwhelming: exercise is not just supportive—it’s a therapeutic intervention that recalibrates tumor biology, enhances treatment tolerance, and improves survival outcomes. Today’s interview features Dr. Kerry Courneya. With over 600 peer-reviewed studies, he is one of the most influential figures in exercise oncology. Even if you aren't someone who has personally experienced cancer in one form or another, you need to watch this episode. Episode 99 is Available now on X, YouTube, Spotify, and Apple Podcasts. Chapters: 0:00 - Introduction 1:47 - Why exercise should be effortful 2:33 - How to meaningfully reduce risk of cancer 6:22 - What type of exercise is best? 7:59 - How exercise reduces risk—even for smokers and the obese 10:48 - Weekend-only exercise 13:49 - 150 vs. 300 minutes per week (more is better—up to a point) 16:03 - Why pre-diagnosis exercise matters 19:09 - Why resilience to cancer treatment starts with exercise 21:01 - Why low muscle mass drives cancer death 23:58 - Why BMI fails to measure true obesity 27:51 - Why daily activity isn't enough (structured exercise matters) 29:34 - Breaking up sedentary time—do ‘exercise snacks’ help? 31:50 - Supplements vs. exercise 32:32 - Where exercise fits with chemo and immunotherapy 35:30 - Why rest is not the best medicine 41:20 - Aerobic vs. resistance 42:13 - How weight training improves 'chemo completion' 44:41 - Why exercise creates vulnerability in cancer cells (limitations do apply) 47:09 - Why exercise might be crucial for tumor elimination 53:03 - Why cardio may be better at clearing tumor cells 56:18 - When cancer spreads quickly—and when it doesn't 57:43 - Why liquid biopsies may prevent over-treatment 1:02:56 - Exercise-sensitive vs. exercise-resistant cancers 1:06:06 - Prostate cancer therapy—why strength training matters 1:08:10 - When exercise is the only therapy—does it work? 1:09:26 - Why HIIT reduces PSA in prostate cancer 1:11:40 - Avoiding overtreatment—can exercise buy you time? 1:12:00 - Why high-intensity exercise boosts anti-cancer biology 1:13:11 - Turning a diagnosis into a wake-up call 1:16:11 - Why oncologists are rethinking exercise 1:18:50 - Why exercise eases anxiety about cancer—proven psychological benefits 1:25:00 - Before, during, and after treatment 1:27:02 - Why exercise is unique among cancer therapies 1:28:16 - Why cancer patients stop exercising—the risky mistake almost everyone makes 1:30:41 - How to get sedentary cancer patients exercising (realistically) 1:33:15 - The $1 million case for including exercise 1:34:56 - Why recurrence trials haven't convinced doctors—yet 1:37:36 - The bottom-line message 1:37:55 - The myth of a cancer panacea (exercise included) 1:44:07 - What's the best $50 investment for staying active? 1:44:40 - Only 15 minutes per day—what’s the best anti-cancer exercise?

Dr. Rhonda Patrick

219,900 Aufrufe • vor 1 Jahr

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,297 Aufrufe • vor 29 Tagen

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.

Camus

38,499 Aufrufe • vor 6 Monaten

A groundbreaking new study published in Cancer Discovery reveals that certain cancers may be detectable in the blood up to three years earlier than current diagnostic methods allow. This could revolutionize early detection—and survival rates. Dr. Patrick Soon-Shiong, a pioneer in cancer research, breaks down the findings: "This study is a game-changer. By analyzing circulating tumor DNA (ctDNA)—genetic material shed by cancer into the bloodstream—researchers identified cancer mutations years before standard diagnosis. This isn’t just about early detection; it’s about monitoring recurrence post-treatment to catch metastasis before it spreads." Why This Matters: 🔹 Early Detection Saves Lives – The sooner cancer is found, the better the odds of successful treatment. 🔹 Peripheral Blood Holds the Key – The study highlights that simple blood tests (like cell-free DNA analysis) may outperform invasive biopsies and imaging for early signals. 🔹 Beyond Diagnosis – These tests could track survivors (like the patient mentioned) to ensure cancer doesn’t return silently. The Future? Imagine a world where routine blood work screens for cancer years before symptoms appear—turning a deadly disease into a manageable condition. This study brings us one step closer. "The answers aren’t just in high-tech scans—they’re in the peripheral blood we’ve overlooked for decades," says Dr. Soon-Shiong. "The era of precision prevention is here." Stay tuned. The fight against cancer just got smarter.

A groundbreaking new study published in Cancer Discovery reveals that certain cancers may be detectable in the blood up to three years earlier than current diagnostic methods allow. This could revolutionize early detection—and survival rates. Dr. Patrick Soon-Shiong, a pioneer in cancer research, breaks down the findings: "This study is a game-changer. By analyzing circulating tumor DNA (ctDNA)—genetic material shed by cancer into the bloodstream—researchers identified cancer mutations years before standard diagnosis. This isn’t just about early detection; it’s about monitoring recurrence post-treatment to catch metastasis before it spreads." Why This Matters: 🔹 Early Detection Saves Lives – The sooner cancer is found, the better the odds of successful treatment. 🔹 Peripheral Blood Holds the Key – The study highlights that simple blood tests (like cell-free DNA analysis) may outperform invasive biopsies and imaging for early signals. 🔹 Beyond Diagnosis – These tests could track survivors (like the patient mentioned) to ensure cancer doesn’t return silently. The Future? Imagine a world where routine blood work screens for cancer years before symptoms appear—turning a deadly disease into a manageable condition. This study brings us one step closer. "The answers aren’t just in high-tech scans—they’re in the peripheral blood we’ve overlooked for decades," says Dr. Soon-Shiong. "The era of precision prevention is here." Stay tuned. The fight against cancer just got smarter.

Camus

18,055 Aufrufe • vor 1 Jahr

Daily coffee is linked to lower cancer risk by protecting your DNA Randomized data show that drinking caffeinated Robusta coffee daily cut DNA double-stranded breaks in blood cells by ~23% versus water These double-stranded breaks are the most dangerous form of DNA damage, driving oncogenic mutations (that can lead to cancer) and accelerating biological aging Coffee’s rich polyphenols directly reduce this DNA damage, potentially lowering cancer risk, preserving telomeres, and supporting long-term genomic stability

Daily coffee is linked to lower cancer risk by protecting your DNA Randomized data show that drinking caffeinated Robusta coffee daily cut DNA double-stranded breaks in blood cells by ~23% versus water These double-stranded breaks are the most dangerous form of DNA damage, driving oncogenic mutations (that can lead to cancer) and accelerating biological aging Coffee’s rich polyphenols directly reduce this DNA damage, potentially lowering cancer risk, preserving telomeres, and supporting long-term genomic stability

FoundMyFitness Clips

28,781 Aufrufe • vor 5 Monaten

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

117,774 Aufrufe • vor 1 Jahr

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

skymeds store | Online Ivermectin Pharmacy

5,142,525 Aufrufe • vor 1 Jahr

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

78,082 Aufrufe • vor 8 Monaten